峰瑞资本

峰瑞资本

@author-1781068851320

504 articles

Articles

Another New Retail Unicorn Emerges: FreeS Fund Angel-Round Project Huasheng Haoche Closes $210M Series B | FreeS Funding News

FreeS Fund continued to increase its stake.

峰瑞资本·

Li Feng's Column 13: China Is at Its Most Precious Historical Moment | Frees Fund

Over four decades of turbulence, the darkest days have always given rise to market opportunities.

峰瑞资本·

FreeS Fund II Completes First Close, New Launches, Awards... 13 Updates and 4 Insights | FreeS Fund Blackboard · September

Stay grounded, keep pushing forward.

峰瑞资本·

Li Feng Column 12: A Speculation on the Endgame of China's New Retail | Frees Fund

Short-term: traffic. Medium-term: efficiency. Long-term: supply chain.

峰瑞资本·

Li Feng Column 11: The Middle Path for New Retail | Frees Fund

The Three Axes of Understanding New Retail

峰瑞资本·

Top 5/15/50/100, Going Global to India, Teaming Up with Tencent on IVI... 13 Takeaways and 8 Insights | FreeS Chalkboard · August

"Choose the more long-term path, even if it's the harder one."

峰瑞资本·

From One Person to 1,000: How to Find and Hire People Through Every Painful Transformation | FreeS Talk

150 people is a tipping point. It's the most dangerous moment, when company culture gets diluted and washed out.

峰瑞资本·

ByteDance HRD Du Hong: What Can Startup HR Actually Do for a CEO? | FreeS Fund Free Talk

Are values really that big and empty? No.

峰瑞资本·

Exploring Ten Thousand Possibilities for Matcha: Guancha Raises Tens of Millions in Series A | FreeS Fund Investment News

"I've prepared enough patience for Guancha, and I'm young enough."

峰瑞资本·

Securing Strategic Investment, Rocket Tests, the "Iron Triangle Initiative"... 7 Developments and 3 Insights | FreeS Fund Blackboard · July

Getting it right matters more than making it easy.

峰瑞资本·

FreeS Report 14: Cosmetics Keep Getting Pricier, But Is Your Face Really Worth a Million? | Frees Fund

Optimistic about startups carving out a slice of the mass-market cosmetics pie.

峰瑞资本·

IQVIA Makes a Move in China, "Nuoxin Chuanglian" Raises Tens of Millions of RMB in A+ Strategic Round | FreeS Fund Deal News

Version 2.0 pharmaceutical marketing digitalization solution.

峰瑞资本·